Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for November 17th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 17th:

Semler Scientific, Inc. (SMLR - Free Report) : This company that develops, manufactures, and markets proprietary products that assist healthcare providers has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.7% over the last 60 days.

 

Semler Scientific’s shares gained 36.6% over the last one month compared with the S&P 500’s growth of 4.1%. The company possesses a Momentum Score of A.

 

Fulgent Genetics, Inc. (FLGT - Free Report) : This genetic testing services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Fulgent Genetics’ shares gained nearly 29% over the last one month. The company possesses a Momentum Score of A.

 

Charles & Colvard, Ltd. (CTHR - Free Report) : This company that manufacture, market and distribute moissanite jewels has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

 

Charles & Colvard’s shares gained 15.7% over the last one month. The company possesses a Momentum Score of A.

 

Regional Management Corp. (RM - Free Report) : This diversified consumer finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.3% over the last 60 days.

 

Regional Management’s shares gained 15.9% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027. 

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>

Published in